News About: Pharm. Industry
Choongwae to envision 1 trillion won of annual sales.
Choongwae plans to establish a stock holding company on July 1. By taking this opportunity, Choongwae tries to transform itself as a global comprehensive healthcare corporation embracing not only pharmaceuticals but a...
Now is a good time for investors to buy pharmaceutical stock prices.
Despite a recent bull's market trends of overall industry stocks, the shares of pharmaceutical industries remained in bear stances. However, considering that overall unfavorable conditions linked with the drug industr...
Three drug makers seek bigger market share
Three pharmaceutical firms SK Chemical, Pacific Pharm and Jeil Pharm are gearing up to boost its marketing activities in the domestic cataplaster market showing a sluggish trend, apparently perturbed by growing numb...
Government drafts plans for FTA-damaged pharmaceutical sectorFollowing the clinching of a free trade agreement with the United States last month, the government will finalize its plan to support the domestic research and development (R&D)...
|
Leading drug makers bite bigger share in ethical market
Major pharmaceutical firms, including Daewoong Pharm and Hanmi Pharm, increased their share of the pie in the domestic ethical market, according to a report released by Woori Investment and Secruities on May 17.
Th...
Wholesaler margin thinner
Domestic drug wholesalers have seen their profit margins worsening for the past few years as domestic and foreign drug markers' continuous margin cut negatively affected their bottom lines, according to pharmaceutical...
Court accepted Ahngook's interim injunction for Lebotension sales.
Ahngook earlier filed an interim injunction to the court against the lawsuit for the sales suspension of "Lebotension". Now, the court accepted the injunction.
On Feb. 28 this year Pfizer filed an interim injuncti...
Allergan Korea faces damage suit
Hanall Pharm said on May 16 it has decided to seek 2.0 billion won in compensation from Allergan Korea for its defamed company image.
Hanall has marketed BTXA, which is in a direct competition with Allergan Korea's...
KFDA approves new anticancer drugThe Korea Food and Drug Administration approved a home-grown anticancer medicine CreaVax-RCC developed by Creagene Inc., a local bio-venture company, for sale in the domestic ma...
|
Pfizer Korea to launch a first new quit-smoking drug soon.Pfizer Korea may advance the market launching of Champix (varenicline), a first oral stop-smoking prescription drug, in mid-May after the KFDA approval in March this year.
C...
|
